Ipilimumab vs Spironolactone

## Ipilimumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Spironolactone**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Spironolactone**: Mineralocorticoid receptor antagonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Spironolactone — 1.4 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Spironolactone — C24H32O4S.

**Molecular Weight**: Ipilimumab — N/A; Spironolactone — 416.5740 g/mol.

**Type**: Ipilimumab — Antibody; Spironolactone — Small molecule.